A groundbreaking blood test can detect multiple cancers early with high accuracy using cell-free DNA analysis.

SLC35B1 transports ATP into the ER, and its structure offers potential for targeted therapies in diseases linked to ER stress ...

Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin ...

This time around, the company is showing that it can get an actual logical qubit into a variant of the same hardware. In the ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...

This study presents an intrinsic capacity clock, using blood samples to predict mortality risk and enhance understanding of ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such ...

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

BioNTech SE's $11.1B oncology move signals potential, but clinical hurdles remain. Click for my look at the BNTX deal with ...

Targeted design for test, better fault models, and in-system testing must keep pace with advanced-node components.

Day One Biopharmaceuticals' Q1'25 sales grew modestly, but Q2 2025 earnings could spark movement. Read why I currently rate ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.